News • Targeted therapy
Biliary duct cancer: the future of precision oncology
Gene alterations in biliary tract cancer offer potential targets for current or future precision therapies. This is demonstrated by a new study from Vienna.
Oncology
News • Potential for new treatments
Researchers find new subtypes for ovarian cancer
New research from the University of Helsinki increases the understanding of ovarian cancer: the identification of new subtypes could help discover new treatments.
Article • 21-day radiotherapy
A safe and effective “shortcut” for early breast cancer treatment
Patients with early-stage breast cancer who have an elevated risk of having tumour recurrence now have the option to take a course of radiotherapy following breast conservation surgery that is only three weeks long, half the time of conventional radiotherapy treatment.
News • Imaging equipment
Dunlee unveils oncology bundles at ECR 2023
Dunlee unveiled its new oncology bundles onsite at ECR. The bundles combine components that have been tested and verified to work together so clinicians can offer state-of-the-art onboard Cone Beam CT (CBCT) in facilities.
News • Radiotherapy trial
Prostate cancer: radical approach greatly reduces treatment visits
A new clinical trial has shown that men diagnosed with prostate cancer can benefit from ‘radical radiotherapy’ that delivers treatment in five hospital visits instead of the typical 20.
News • Protein controls resistance
Targeted approach holds promise to improve chemotherapy
Chemotherapy resistance is a main cause of treatment failure and death in cancer patients. Researchers from Brussels found how cancer cells protect themselves from the aggressive treatment.
News • Blood cancer research
Novel disease models for multiple myeloma
A team of scientists has successfully generated genetically defined mouse models for two subtypes of multiple myeloma. This will contribute to a better understanding of how the disease develops in humans.
News • MR-Linac measures oxygen levels
One step closer to targeted real time treatment of hypoxic cancers
Imaging researchers have taken a major step towards their ultimate goal of identifying cancers that are starved of oxygen so that altered treatment can be used to target them more effectively.
Article • Existing solutions need to mature, experts find
Interactive mobile cancer apps: promising, but formative
Interactive mobile apps have become ubiquitous in daily life. The Covid-19 pandemic has escalated the use of disease-specific monitoring apps. Mobile apps enabling cancer patients to self-manage their physical condition and symptoms can help them to evaluate toxic side effects of their treatments, offer artificial intelligence (AI)-generated recommendations to minimize them, and alert them to…
News • Randomness as resistance strategy
Cancer response to chemotherapy: a game of chance?
Cancer cells have an innate randomness in their ability to respond to chemotherapy, which is another tool in their arsenal of resisting treatment, new research shows.
News • Optional treatment
Radiotherapy: no benefits for older patients with early breast cancer
Radiotherapy does not improve survival rates in older patients with early breast cancer, new research suggests.
Article • Radioembolization
Breast cancer metastasis: benefits and limitations of trans-arterial therapy
Evidence that radioembolization, a trans-arterial therapy, is safe and stops disease progression in metastatic breast cancer is increasing, a prominent American interventional radiologist showed at the Spectrum conference in Miami.
News • Potential of immunotherapy explored
Surgery first for colon cancer? Not so fast, says new study
Immunotherapy prior to surgery is surprisingly effective for patients with a certain type of colorectal cancer (dMMR/MSI-H CRC). These new study results contrast current treatment regimens.
News • Hereditary non-polyposis colorectal cancer
Lynch syndrome: AI improves colorectal cancer screening
Researchers have now found that artificial intelligence (AI) can improve the effectiveness of colonoscopy in the presence of Lynch syndrome.
News • Patient-derived whole-tumor cell culture model
Breast cancer: New method finds the right therapy
Swedish researchers have developed a method that should be able to predict whether a patient with breast cancer will benefit from a particular treatment or not.
News • Prevalence of metastatic BRCA
New research shows scale of secondary breast cancer in England
A cancer researcher and consultant has estimated for the first time how many women are living with secondary breast cancer in England – in new research which could help to shape cancer services.
News • Prolonging life vs. maintaining functionality
Cancer treatment goals: patients and doctors often not on the same page
Prolonging life may not be a top priority for everyone: New research finds that patients with neuroendocrine tumours and their doctors often disagree when it comes to treatment goals.
Article • Mid-treatment scans can reduce treatment sessions
De-escalating radiation therapy for oropharynx cancer with FDG-PET
Using fluorodeoxyglucose positron emission tomography (FDG-PET) imaging may give insights into possible dose reductions in ongoing radiation therapy of head and neck cancer. A promising study to explore this option was presented at the 2022 ASTRO/ASCO Multidisciplinary Head and Cancer Symposium held in Phoenix, Arizona.
News • Precision medicine
Localising BRCA gene mutations to better treat ovarian cancer
An international team highlights the importance of localising BRCA1 and BRCA2 gene mutations for the treatment of ovarian cancer.
Article • AI-based personalized medical care
I³lung: EU launches lung cancer initiative
This summer, The European Commission launched I3lung, a new research initiative as a part of Horizon Europe, the EU’s research and innovation program. This research initiative aims to create a cutting-edge, decision-making tool to help clinicians and patients select the best lung cancer treatment based on each patient’s specific needs and circumstances.
News • Oncology forecast
Is Europe facing a 'cancer epidemic' in the next decade?
With an estimated one million cancer diagnoses missed across Europe in the last two years, the impact of the Covid-19 pandemic is predicted to set back European cancer outcomes by almost a decade.
Article • Early detection approach
Multi-cancer blood tests could shake up screening
New tests can identify over 50 types of cancer and boost detection of traditionally elusive cancers from tumour DNA in blood, researchers showed at the ESMO congress in September. These multi-cancer early detection (MCED) tests in development can spot common cancer signals and predict where the signal comes from in the body, results from a prospective investigation suggest.
Article • Visceral imaging
Endosonography: AI takes on the “supreme discipline”
Endosonography poses unique challenges for medical professionals, because two demanding disciplines have to be mastered at the same time. The use of artificial intelligence (AI) could help speed up the notoriously slow learning curve of the procedure, says Prof Dr Christoph F. Dietrich. At the Visceral Medicine Congress in Hamburg, the expert explained how AI can help endosonography achieve…
News • Stereotactic body radiotherapy
Advanced radiotherapy speeds up prostate cancer treatment
An advanced radiotherapy technique can be used to safely treat prostate cancer patients in as little as one to two weeks, compared with the current standard, which takes one to two months.
News • Nasopharyngeal cancer study
Covid vaccination improves effectiveness of cancer treatment
Until now, it was feared that vaccination against Covid-19 could reduce the success of treatment for patients with nasopharyngeal cancer. A recent study now gives the all-clear in this regard.
